| Literature DB >> 10452242 |
S Yasuda1, H Makuuchi, S Sadahiro, M Mukai, H Ishida, N Tokunaga, T Kimura, T Tajima, A Shohtsu.
Abstract
Increased glucose metabolism has been reported to occur in association with colorectal cancer. As positron emission tomography (PET) using [18F]fluorodeoxyglucose is able to depict hypermetabolic sites, it can therefore be used to detect colorectal cancer. A 69-year-old male patient with a recurrent solitary liver metastasis from colon cancer underwent whole-body PET which revealed high [18F]fluorodeoxyglucose uptake in the lesion. Furthermore, PET revealed peritoneal metastases that had not been detected by conventional imaging methods. Consequently, PET proved useful in helping us to avoid performing unnecessary treatment for the liver metastasis. Although it is uncertain whether early identification of recurrence can prolong survival, it may help to prevent unnecessary treatments being carried out. Thus, the application of PET in carefully selected patients could be beneficial to the management of recurrent colorectal cancer.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10452242 DOI: 10.1007/BF02482990
Source DB: PubMed Journal: Surg Today ISSN: 0941-1291 Impact factor: 2.549